Literature DB >> 19499039

Detection of hemochromatosis through the analysis of single- nucleotide extension products by capillary electrophoresis.

Q Liang1, P A Davis, J T Simpson, B H Thompson, J M Devaney, J Girard.   

Abstract

Hereditary hemochromatosis is one of the most common hereditary disorders in Caucasians.The disease is linked to two single-nucleotide polymorphisms (SNPs) in the HFE gene.The two point mutations result in a change of Cys to Tyr at position 282 and His to Asp at position 63 in the resultant protein.We have developed a single-nucleotide extension (SNE) assay for hereditary hemochromatosis genetic testing, which employs capillary electrophoresis to simultaneously detect the SNE products generated from the two SNP sites. An upstream or a downstream primer adjacent to the possible mutation site is designed and extended one nucleotide further at the 3' end, complementary to the nucleotide at the possible mutation site.The extended nucleotide is one of four fluorescently labeled dideoxynucleotide triphosphates that also act as terminators. Analysis of the extended products by laser-induced fluorescence capillary electrophoresis (LIF-CE) directly reflects the identity of the possible mutation site. Using one primer upstream or downstream from the possible mutation site, three genotypes at one mutation site can be distinguished. Using both upstream and downstream primers provides a second level of specificity and increases the accuracy of the genetic test. The protocol can also be applied to the study of other SNP analyses and to simultaneous detection of multiple mutation sites.

Entities:  

Year:  2000        PMID: 19499039      PMCID: PMC2291624     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  17 in total

1.  Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography.

Authors:  B Hoogendoorn; M J Owen; P J Oefner; N Williams; J Austin; M C O'Donovan
Journal:  Hum Genet       Date:  1999-01       Impact factor: 4.132

2.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations.

Authors:  M K Stott; A P Fellowes; J D Upton; M J Burt; P M George
Journal:  Clin Chem       Date:  1999-03       Impact factor: 8.327

Review 4.  Diagnosis of hemochromatosis.

Authors:  L W Powell; D K George; S M McDonnell; K V Kowdley
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

5.  H63D is an haemochromatosis associated allele.

Authors:  V F Fairbanks; D J Brandhagen; S N Thibodeau; K Snow; P C Wollan
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

6.  Rapid genetic screening for haemochromatosis using heteroduplex technology.

Authors:  H A Jackson; D J Bowen; M Worwood
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

7.  Automated DNA purification and amplification from blood-stained cards using a robotic workstation.

Authors:  P Belgrader; S A Del Rio; K A Turner; M A Marino; K R Weaver; P E Williams
Journal:  Biotechniques       Date:  1995-09       Impact factor: 1.993

8.  A PCR-SSP method for detecting the Cys282Tyr mutation in the HFE gene associated with hereditary haemochromatosis.

Authors:  D Smillie
Journal:  Mol Pathol       Date:  1997-10

9.  A rapid automated SSCP multiplex capillary electrophoresis protocol that detects the two common mutations implicated in hereditary hemochromatosis (HH).

Authors:  H M Wenz; S Baumhueter; S Ramachandra; M Worwood
Journal:  Hum Genet       Date:  1999-01       Impact factor: 4.132

Review 10.  Hereditary hemochromatosis: gene discovery and its implications for population-based screening.

Authors:  W Burke; E Thomson; M J Khoury; S M McDonnell; N Press; P C Adams; J C Barton; E Beutler; G Brittenham; A Buchanan; E W Clayton; M E Cogswell; E M Meslin; A G Motulsky; L W Powell; E Sigal; B S Wilfond; F S Collins
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.